nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—CDK7—lymphoid tissue—Creutzfeldt-Jakob disease	0.0041	0.00605	CbGeAlD
Crizotinib—EPHA4—brainstem—Creutzfeldt-Jakob disease	0.00376	0.00554	CbGeAlD
Crizotinib—PRKD1—central nervous system—Creutzfeldt-Jakob disease	0.00375	0.00553	CbGeAlD
Crizotinib—JAK3—lymphoid tissue—Creutzfeldt-Jakob disease	0.00374	0.00552	CbGeAlD
Crizotinib—SIK2—central nervous system—Creutzfeldt-Jakob disease	0.0037	0.00546	CbGeAlD
Crizotinib—PLK4—lymphoid tissue—Creutzfeldt-Jakob disease	0.00369	0.00545	CbGeAlD
Crizotinib—STK4—lymphoid tissue—Creutzfeldt-Jakob disease	0.00367	0.00542	CbGeAlD
Crizotinib—PRKD1—cerebellum—Creutzfeldt-Jakob disease	0.00367	0.00541	CbGeAlD
Crizotinib—LIMK1—cerebellum—Creutzfeldt-Jakob disease	0.00362	0.00534	CbGeAlD
Crizotinib—PRKD3—cerebellum—Creutzfeldt-Jakob disease	0.00353	0.0052	CbGeAlD
Crizotinib—TYRO3—lymphoid tissue—Creutzfeldt-Jakob disease	0.00347	0.00512	CbGeAlD
Crizotinib—ALK—lymphoid tissue—Creutzfeldt-Jakob disease	0.00347	0.00512	CbGeAlD
Crizotinib—FER—lymphoid tissue—Creutzfeldt-Jakob disease	0.00347	0.00512	CbGeAlD
Crizotinib—LYN—lymphoid tissue—Creutzfeldt-Jakob disease	0.00345	0.00509	CbGeAlD
Crizotinib—DSTYK—cerebellum—Creutzfeldt-Jakob disease	0.00344	0.00508	CbGeAlD
Crizotinib—MAP4K1—lymphoid tissue—Creutzfeldt-Jakob disease	0.0034	0.00501	CbGeAlD
Crizotinib—DCLK1—spinal cord—Creutzfeldt-Jakob disease	0.00337	0.00497	CbGeAlD
Crizotinib—CASK—cerebellum—Creutzfeldt-Jakob disease	0.00336	0.00496	CbGeAlD
Crizotinib—IGF1R—lymphoid tissue—Creutzfeldt-Jakob disease	0.00333	0.00492	CbGeAlD
Crizotinib—MAPK7—central nervous system—Creutzfeldt-Jakob disease	0.00333	0.00492	CbGeAlD
Crizotinib—EPHA8—central nervous system—Creutzfeldt-Jakob disease	0.0033	0.00487	CbGeAlD
Crizotinib—MAP4K2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00329	0.00485	CbGeAlD
Crizotinib—NEK9—brain—Creutzfeldt-Jakob disease	0.00327	0.00482	CbGeAlD
Crizotinib—MAPK7—cerebellum—Creutzfeldt-Jakob disease	0.00326	0.0048	CbGeAlD
Crizotinib—EPHA8—cerebellum—Creutzfeldt-Jakob disease	0.00322	0.00476	CbGeAlD
Crizotinib—AURKA—lymphoid tissue—Creutzfeldt-Jakob disease	0.00316	0.00466	CbGeAlD
Crizotinib—FER—spinal cord—Creutzfeldt-Jakob disease	0.00315	0.00464	CbGeAlD
Crizotinib—TYRO3—spinal cord—Creutzfeldt-Jakob disease	0.00315	0.00464	CbGeAlD
Crizotinib—EPHA5—spinal cord—Creutzfeldt-Jakob disease	0.00315	0.00464	CbGeAlD
Crizotinib—MET—central nervous system—Creutzfeldt-Jakob disease	0.00312	0.0046	CbGeAlD
Crizotinib—MET—cerebellum—Creutzfeldt-Jakob disease	0.00305	0.0045	CbGeAlD
Crizotinib—MERTK—lymphoid tissue—Creutzfeldt-Jakob disease	0.00305	0.0045	CbGeAlD
Crizotinib—CDK7—central nervous system—Creutzfeldt-Jakob disease	0.00302	0.00445	CbGeAlD
Crizotinib—LIMK2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00298	0.0044	CbGeAlD
Crizotinib—PRKD1—brain—Creutzfeldt-Jakob disease	0.00298	0.00439	CbGeAlD
Crizotinib—FLT3—lymphoid tissue—Creutzfeldt-Jakob disease	0.00295	0.00435	CbGeAlD
Crizotinib—CDK7—cerebellum—Creutzfeldt-Jakob disease	0.00295	0.00435	CbGeAlD
Crizotinib—LIMK1—brain—Creutzfeldt-Jakob disease	0.00294	0.00433	CbGeAlD
Crizotinib—SIK2—brain—Creutzfeldt-Jakob disease	0.00294	0.00433	CbGeAlD
Crizotinib—TAOK2—cerebellum—Creutzfeldt-Jakob disease	0.00293	0.00432	CbGeAlD
Crizotinib—EPHA3—central nervous system—Creutzfeldt-Jakob disease	0.00288	0.00425	CbGeAlD
Crizotinib—ACVR1B—central nervous system—Creutzfeldt-Jakob disease	0.00288	0.00425	CbGeAlD
Crizotinib—TAOK3—brainstem—Creutzfeldt-Jakob disease	0.00286	0.00423	CbGeAlD
Crizotinib—PRKD3—brain—Creutzfeldt-Jakob disease	0.00286	0.00422	CbGeAlD
Crizotinib—TESK1—spinal cord—Creutzfeldt-Jakob disease	0.00284	0.00419	CbGeAlD
Crizotinib—ACVR1B—cerebellum—Creutzfeldt-Jakob disease	0.00282	0.00416	CbGeAlD
Crizotinib—DSTYK—brain—Creutzfeldt-Jakob disease	0.0028	0.00412	CbGeAlD
Crizotinib—EPHA6—central nervous system—Creutzfeldt-Jakob disease	0.00275	0.00406	CbGeAlD
Crizotinib—JAK3—central nervous system—Creutzfeldt-Jakob disease	0.00275	0.00406	CbGeAlD
Crizotinib—DCLK1—central nervous system—Creutzfeldt-Jakob disease	0.00273	0.00403	CbGeAlD
Crizotinib—LTK—brain—Creutzfeldt-Jakob disease	0.00273	0.00403	CbGeAlD
Crizotinib—CASK—brain—Creutzfeldt-Jakob disease	0.00273	0.00403	CbGeAlD
Crizotinib—LIMK2—spinal cord—Creutzfeldt-Jakob disease	0.0027	0.00399	CbGeAlD
Crizotinib—STK4—central nervous system—Creutzfeldt-Jakob disease	0.0027	0.00398	CbGeAlD
Crizotinib—JAK3—cerebellum—Creutzfeldt-Jakob disease	0.00269	0.00397	CbGeAlD
Crizotinib—PTK2B—lymphoid tissue—Creutzfeldt-Jakob disease	0.00269	0.00396	CbGeAlD
Crizotinib—MAP3K12—spinal cord—Creutzfeldt-Jakob disease	0.00267	0.00395	CbGeAlD
Crizotinib—ACVR1—spinal cord—Creutzfeldt-Jakob disease	0.00267	0.00395	CbGeAlD
Crizotinib—DCLK1—cerebellum—Creutzfeldt-Jakob disease	0.00267	0.00394	CbGeAlD
Crizotinib—MAPK7—brain—Creutzfeldt-Jakob disease	0.00265	0.0039	CbGeAlD
Crizotinib—STK4—cerebellum—Creutzfeldt-Jakob disease	0.00264	0.00389	CbGeAlD
Crizotinib—EPHA8—brain—Creutzfeldt-Jakob disease	0.00262	0.00386	CbGeAlD
Crizotinib—FES—brain—Creutzfeldt-Jakob disease	0.00262	0.00386	CbGeAlD
Crizotinib—RPS6KB1—a6b1 and a6b4 Integrin signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00258	0.008	CbGpPWpGaD
Crizotinib—LCK—PD-1 signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00257	0.00797	CbGpPWpGaD
Crizotinib—RIPK2—TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00255	0.00793	CbGpPWpGaD
Crizotinib—EPHA5—central nervous system—Creutzfeldt-Jakob disease	0.00255	0.00376	CbGeAlD
Crizotinib—TYRO3—central nervous system—Creutzfeldt-Jakob disease	0.00255	0.00376	CbGeAlD
Crizotinib—FER—central nervous system—Creutzfeldt-Jakob disease	0.00255	0.00376	CbGeAlD
Crizotinib—ALK—central nervous system—Creutzfeldt-Jakob disease	0.00255	0.00376	CbGeAlD
Crizotinib—LYN—central nervous system—Creutzfeldt-Jakob disease	0.00254	0.00374	CbGeAlD
Crizotinib—MAP3K2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00253	0.00373	CbGeAlD
Crizotinib—BMP2K—spinal cord—Creutzfeldt-Jakob disease	0.00252	0.00372	CbGeAlD
Crizotinib—MAP3K19—central nervous system—Creutzfeldt-Jakob disease	0.0025	0.00369	CbGeAlD
Crizotinib—BMPR1B—central nervous system—Creutzfeldt-Jakob disease	0.0025	0.00369	CbGeAlD
Crizotinib—FER—cerebellum—Creutzfeldt-Jakob disease	0.00249	0.00368	CbGeAlD
Crizotinib—TYRO3—cerebellum—Creutzfeldt-Jakob disease	0.00249	0.00368	CbGeAlD
Crizotinib—EPHA5—cerebellum—Creutzfeldt-Jakob disease	0.00249	0.00368	CbGeAlD
Crizotinib—MET—brain—Creutzfeldt-Jakob disease	0.00248	0.00365	CbGeAlD
Crizotinib—PTK2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00247	0.00365	CbGeAlD
Crizotinib—TBK1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00247	0.00365	CbGeAlD
Crizotinib—TNK1—cerebellum—Creutzfeldt-Jakob disease	0.00247	0.00364	CbGeAlD
Crizotinib—TYK2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00246	0.00363	CbGeAlD
Crizotinib—TNK2—central nervous system—Creutzfeldt-Jakob disease	0.00245	0.00362	CbGeAlD
Crizotinib—IGF1R—central nervous system—Creutzfeldt-Jakob disease	0.00245	0.00362	CbGeAlD
Crizotinib—PRKD1—Calcium Regulation in the Cardiac Cell—YWHAZ—Creutzfeldt-Jakob disease	0.00245	0.0076	CbGpPWpGaD
Crizotinib—BMPR1B—cerebellum—Creutzfeldt-Jakob disease	0.00244	0.0036	CbGeAlD
Crizotinib—RIPK2—spinal cord—Creutzfeldt-Jakob disease	0.00242	0.00356	CbGeAlD
Crizotinib—TNK2—cerebellum—Creutzfeldt-Jakob disease	0.0024	0.00353	CbGeAlD
Crizotinib—IGF1R—cerebellum—Creutzfeldt-Jakob disease	0.0024	0.00353	CbGeAlD
Crizotinib—CDK7—brain—Creutzfeldt-Jakob disease	0.0024	0.00353	CbGeAlD
Crizotinib—TIE1—central nervous system—Creutzfeldt-Jakob disease	0.00239	0.00352	CbGeAlD
Crizotinib—RPS6KB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00238	0.00351	CbGeAlD
Crizotinib—TAOK2—brain—Creutzfeldt-Jakob disease	0.00238	0.00351	CbGeAlD
Crizotinib—EPHA7—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00238	0.00738	CbGpPWpGaD
Crizotinib—PRKD1—Myometrial Relaxation and Contraction Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00237	0.00736	CbGpPWpGaD
Crizotinib—FGR—lymphoid tissue—Creutzfeldt-Jakob disease	0.00237	0.00349	CbGeAlD
Crizotinib—MAP4K2—cerebellum—Creutzfeldt-Jakob disease	0.00236	0.00349	CbGeAlD
Crizotinib—AXL—lymphoid tissue—Creutzfeldt-Jakob disease	0.00236	0.00348	CbGeAlD
Crizotinib—TIE1—cerebellum—Creutzfeldt-Jakob disease	0.00233	0.00344	CbGeAlD
Crizotinib—STK3—cerebellum—Creutzfeldt-Jakob disease	0.00233	0.00344	CbGeAlD
Crizotinib—AURKA—central nervous system—Creutzfeldt-Jakob disease	0.00232	0.00343	CbGeAlD
Crizotinib—TESK1—central nervous system—Creutzfeldt-Jakob disease	0.00231	0.0034	CbGeAlD
Crizotinib—ACVR1B—brain—Creutzfeldt-Jakob disease	0.00229	0.00338	CbGeAlD
Crizotinib—EPHA3—brain—Creutzfeldt-Jakob disease	0.00229	0.00338	CbGeAlD
Crizotinib—JAK2—IL3-mediated signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00229	0.00711	CbGpPWpGaD
Crizotinib—EPHA2—Direct p53 effectors—CTSD—Creutzfeldt-Jakob disease	0.00227	0.00705	CbGpPWpGaD
Crizotinib—TESK1—cerebellum—Creutzfeldt-Jakob disease	0.00225	0.00332	CbGeAlD
Crizotinib—TBK1—spinal cord—Creutzfeldt-Jakob disease	0.00224	0.00331	CbGeAlD
Crizotinib—PTK2—spinal cord—Creutzfeldt-Jakob disease	0.00224	0.00331	CbGeAlD
Crizotinib—MERTK—central nervous system—Creutzfeldt-Jakob disease	0.00224	0.00331	CbGeAlD
Crizotinib—JAK2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00224	0.0033	CbGeAlD
Crizotinib—TYK2—spinal cord—Creutzfeldt-Jakob disease	0.00223	0.00329	CbGeAlD
Crizotinib—YES1—Interleukin-3, 5 and GM-CSF signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00222	0.00689	CbGpPWpGaD
Crizotinib—CASK—Extracellular matrix organization—CTSD—Creutzfeldt-Jakob disease	0.00221	0.00687	CbGpPWpGaD
Crizotinib—EPHA2—lymphoid tissue—Creutzfeldt-Jakob disease	0.00221	0.00326	CbGeAlD
Crizotinib—PRKD1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.0022	0.00682	CbGpPWpGaD
Crizotinib—LIMK2—central nervous system—Creutzfeldt-Jakob disease	0.00219	0.00324	CbGeAlD
Crizotinib—MERTK—cerebellum—Creutzfeldt-Jakob disease	0.00219	0.00323	CbGeAlD
Crizotinib—MET—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00219	0.00679	CbGpPWpGaD
Crizotinib—EPHA6—brain—Creutzfeldt-Jakob disease	0.00218	0.00322	CbGeAlD
Crizotinib—JAK3—brain—Creutzfeldt-Jakob disease	0.00218	0.00322	CbGeAlD
Crizotinib—MAPK7—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00217	0.00674	CbGpPWpGaD
Crizotinib—DCLK1—brain—Creutzfeldt-Jakob disease	0.00217	0.0032	CbGeAlD
Crizotinib—ACVR1—central nervous system—Creutzfeldt-Jakob disease	0.00217	0.0032	CbGeAlD
Crizotinib—MAP3K12—central nervous system—Creutzfeldt-Jakob disease	0.00217	0.0032	CbGeAlD
Crizotinib—RPS6KB1—spinal cord—Creutzfeldt-Jakob disease	0.00216	0.00318	CbGeAlD
Crizotinib—PLK4—brain—Creutzfeldt-Jakob disease	0.00216	0.00318	CbGeAlD
Crizotinib—TEK—lymphoid tissue—Creutzfeldt-Jakob disease	0.00216	0.00318	CbGeAlD
Crizotinib—MAP4K5—lymphoid tissue—Creutzfeldt-Jakob disease	0.00216	0.00318	CbGeAlD
Crizotinib—STK4—brain—Creutzfeldt-Jakob disease	0.00214	0.00316	CbGeAlD
Crizotinib—LIMK2—cerebellum—Creutzfeldt-Jakob disease	0.00214	0.00316	CbGeAlD
Crizotinib—AXL—spinal cord—Creutzfeldt-Jakob disease	0.00214	0.00315	CbGeAlD
Crizotinib—NUAK2—cerebellum—Creutzfeldt-Jakob disease	0.00214	0.00315	CbGeAlD
Crizotinib—STK35—central nervous system—Creutzfeldt-Jakob disease	0.00213	0.00314	CbGeAlD
Crizotinib—ACVR1—cerebellum—Creutzfeldt-Jakob disease	0.00212	0.00313	CbGeAlD
Crizotinib—FLT3—cerebellum—Creutzfeldt-Jakob disease	0.00212	0.00313	CbGeAlD
Crizotinib—MAP3K12—cerebellum—Creutzfeldt-Jakob disease	0.00212	0.00313	CbGeAlD
Crizotinib—NTRK1—Circadian rythm related genes—NPAS2—Creutzfeldt-Jakob disease	0.0021	0.00653	CbGpPWpGaD
Crizotinib—JAK2—NCAM signaling for neurite out-growth—PRNP—Creutzfeldt-Jakob disease	0.0021	0.00651	CbGpPWpGaD
Crizotinib—STK35—cerebellum—Creutzfeldt-Jakob disease	0.00208	0.00306	CbGeAlD
Crizotinib—SLK—spinal cord—Creutzfeldt-Jakob disease	0.00206	0.00303	CbGeAlD
Crizotinib—BMP2K—central nervous system—Creutzfeldt-Jakob disease	0.00205	0.00302	CbGeAlD
Crizotinib—CYP3A5—blood plasma—Creutzfeldt-Jakob disease	0.00204	0.00301	CbGeAlD
Crizotinib—EPHB4—spinal cord—Creutzfeldt-Jakob disease	0.00204	0.00301	CbGeAlD
Crizotinib—JAK2—spinal cord—Creutzfeldt-Jakob disease	0.00203	0.00299	CbGeAlD
Crizotinib—ALK—brain—Creutzfeldt-Jakob disease	0.00203	0.00299	CbGeAlD
Crizotinib—EPHA5—brain—Creutzfeldt-Jakob disease	0.00203	0.00299	CbGeAlD
Crizotinib—TYRO3—brain—Creutzfeldt-Jakob disease	0.00203	0.00299	CbGeAlD
Crizotinib—FER—brain—Creutzfeldt-Jakob disease	0.00203	0.00299	CbGeAlD
Crizotinib—ABL2—cerebellum—Creutzfeldt-Jakob disease	0.00202	0.00299	CbGeAlD
Crizotinib—LYN—brain—Creutzfeldt-Jakob disease	0.00202	0.00297	CbGeAlD
Crizotinib—TNK1—brain—Creutzfeldt-Jakob disease	0.00201	0.00296	CbGeAlD
Crizotinib—BMP2K—cerebellum—Creutzfeldt-Jakob disease	0.002	0.00295	CbGeAlD
Crizotinib—YES1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00199	0.00294	CbGeAlD
Crizotinib—MAP3K19—brain—Creutzfeldt-Jakob disease	0.00198	0.00293	CbGeAlD
Crizotinib—BMPR1B—brain—Creutzfeldt-Jakob disease	0.00198	0.00293	CbGeAlD
Crizotinib—MAP4K1—brain—Creutzfeldt-Jakob disease	0.00198	0.00293	CbGeAlD
Crizotinib—ABL1—brainstem—Creutzfeldt-Jakob disease	0.00198	0.00292	CbGeAlD
Crizotinib—MAP3K2—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00198	0.00614	CbGpPWpGaD
Crizotinib—PTK2B—central nervous system—Creutzfeldt-Jakob disease	0.00198	0.00292	CbGeAlD
Crizotinib—STK10—lymphoid tissue—Creutzfeldt-Jakob disease	0.00197	0.00291	CbGeAlD
Crizotinib—LCK—Generation of second messenger molecules—HLA-DQB1—Creutzfeldt-Jakob disease	0.00197	0.00612	CbGpPWpGaD
Crizotinib—TAOK3—lymphoid tissue—Creutzfeldt-Jakob disease	0.00196	0.0029	CbGeAlD
Crizotinib—TEK—spinal cord—Creutzfeldt-Jakob disease	0.00195	0.00288	CbGeAlD
Crizotinib—MAP3K3—spinal cord—Creutzfeldt-Jakob disease	0.00195	0.00288	CbGeAlD
Crizotinib—MAP4K5—spinal cord—Creutzfeldt-Jakob disease	0.00195	0.00288	CbGeAlD
Crizotinib—TNK2—brain—Creutzfeldt-Jakob disease	0.00195	0.00287	CbGeAlD
Crizotinib—IGF1R—brain—Creutzfeldt-Jakob disease	0.00195	0.00287	CbGeAlD
Crizotinib—PTK2B—cerebellum—Creutzfeldt-Jakob disease	0.00193	0.00285	CbGeAlD
Crizotinib—MAP4K2—brain—Creutzfeldt-Jakob disease	0.00192	0.00283	CbGeAlD
Crizotinib—RIPK2—cerebellum—Creutzfeldt-Jakob disease	0.00192	0.00283	CbGeAlD
Crizotinib—SRC—lymphoid tissue—Creutzfeldt-Jakob disease	0.00191	0.00282	CbGeAlD
Crizotinib—FES—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00191	0.00594	CbGpPWpGaD
Crizotinib—LYN—GMCSF-mediated signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.0019	0.0059	CbGpPWpGaD
Crizotinib—RPS6KB1—mTOR signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.0019	0.00589	CbGpPWpGaD
Crizotinib—EPHA4—central nervous system—Creutzfeldt-Jakob disease	0.00189	0.00279	CbGeAlD
Crizotinib—TIE1—brain—Creutzfeldt-Jakob disease	0.00189	0.00279	CbGeAlD
Crizotinib—STK3—brain—Creutzfeldt-Jakob disease	0.00189	0.00279	CbGeAlD
Crizotinib—EPHB6—spinal cord—Creutzfeldt-Jakob disease	0.00187	0.00275	CbGeAlD
Crizotinib—MAP3K2—central nervous system—Creutzfeldt-Jakob disease	0.00186	0.00274	CbGeAlD
Crizotinib—EPHA4—cerebellum—Creutzfeldt-Jakob disease	0.00185	0.00273	CbGeAlD
Crizotinib—AURKA—brain—Creutzfeldt-Jakob disease	0.00185	0.00272	CbGeAlD
Crizotinib—TESK1—brain—Creutzfeldt-Jakob disease	0.00183	0.0027	CbGeAlD
Crizotinib—PTK2—central nervous system—Creutzfeldt-Jakob disease	0.00182	0.00268	CbGeAlD
Crizotinib—TBK1—central nervous system—Creutzfeldt-Jakob disease	0.00182	0.00268	CbGeAlD
Crizotinib—MAP3K2—cerebellum—Creutzfeldt-Jakob disease	0.00182	0.00268	CbGeAlD
Crizotinib—EPHA3—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00181	0.00563	CbGpPWpGaD
Crizotinib—ABL2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00181	0.00563	CbGpPWpGaD
Crizotinib—EPHA5—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00181	0.00563	CbGpPWpGaD
Crizotinib—TYK2—central nervous system—Creutzfeldt-Jakob disease	0.00181	0.00267	CbGeAlD
Crizotinib—YES1—spinal cord—Creutzfeldt-Jakob disease	0.0018	0.00266	CbGeAlD
Crizotinib—ACVR1B—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.0018	0.00559	CbGpPWpGaD
Crizotinib—TAOK3—spinal cord—Creutzfeldt-Jakob disease	0.00178	0.00263	CbGeAlD
Crizotinib—MERTK—brain—Creutzfeldt-Jakob disease	0.00178	0.00263	CbGeAlD
Crizotinib—PTK2—cerebellum—Creutzfeldt-Jakob disease	0.00178	0.00262	CbGeAlD
Crizotinib—TBK1—cerebellum—Creutzfeldt-Jakob disease	0.00178	0.00262	CbGeAlD
Crizotinib—JAK2—GMCSF-mediated signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00178	0.00552	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00177	0.00549	CbGpPWpGaD
Crizotinib—TYK2—cerebellum—Creutzfeldt-Jakob disease	0.00177	0.00261	CbGeAlD
Crizotinib—YES1—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.00176	0.00548	CbGpPWpGaD
Crizotinib—RPS6KB1—central nervous system—Creutzfeldt-Jakob disease	0.00175	0.00258	CbGeAlD
Crizotinib—EPHA8—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00175	0.00543	CbGpPWpGaD
Crizotinib—IRAK1—cerebellum—Creutzfeldt-Jakob disease	0.00174	0.00257	CbGeAlD
Crizotinib—LIMK2—brain—Creutzfeldt-Jakob disease	0.00174	0.00257	CbGeAlD
Crizotinib—FGR—central nervous system—Creutzfeldt-Jakob disease	0.00174	0.00257	CbGeAlD
Crizotinib—SRC—spinal cord—Creutzfeldt-Jakob disease	0.00174	0.00256	CbGeAlD
Crizotinib—NUAK2—brain—Creutzfeldt-Jakob disease	0.00174	0.00256	CbGeAlD
Crizotinib—AXL—central nervous system—Creutzfeldt-Jakob disease	0.00173	0.00256	CbGeAlD
Crizotinib—EPHB4—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00173	0.00537	CbGpPWpGaD
Crizotinib—EPHA4—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00173	0.00537	CbGpPWpGaD
Crizotinib—LIMK2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00173	0.00537	CbGpPWpGaD
Crizotinib—MAP3K12—brain—Creutzfeldt-Jakob disease	0.00172	0.00254	CbGeAlD
Crizotinib—ACVR1—brain—Creutzfeldt-Jakob disease	0.00172	0.00254	CbGeAlD
Crizotinib—CSF1R—lymphoid tissue—Creutzfeldt-Jakob disease	0.00172	0.00254	CbGeAlD
Crizotinib—RPS6KB1—cerebellum—Creutzfeldt-Jakob disease	0.00171	0.00252	CbGeAlD
Crizotinib—AXL—cerebellum—Creutzfeldt-Jakob disease	0.00169	0.0025	CbGeAlD
Crizotinib—LIMK1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00169	0.00525	CbGpPWpGaD
Crizotinib—STK35—brain—Creutzfeldt-Jakob disease	0.00169	0.00249	CbGeAlD
Crizotinib—MAP3K3—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00166	0.00516	CbGpPWpGaD
Crizotinib—LYN—Interleukin-3, 5 and GM-CSF signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00165	0.00514	CbGpPWpGaD
Crizotinib—ABL2—brain—Creutzfeldt-Jakob disease	0.00164	0.00243	CbGeAlD
Crizotinib—JAK2—central nervous system—Creutzfeldt-Jakob disease	0.00164	0.00243	CbGeAlD
Crizotinib—SLK—cerebellum—Creutzfeldt-Jakob disease	0.00163	0.0024	CbGeAlD
Crizotinib—SRC—NCAM signaling for neurite out-growth—PRNP—Creutzfeldt-Jakob disease	0.00163	0.00505	CbGpPWpGaD
Crizotinib—EPHB6—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00163	0.00505	CbGpPWpGaD
Crizotinib—EPHA2—central nervous system—Creutzfeldt-Jakob disease	0.00162	0.0024	CbGeAlD
Crizotinib—BMP2K—brain—Creutzfeldt-Jakob disease	0.00162	0.0024	CbGeAlD
Crizotinib—EPHB4—cerebellum—Creutzfeldt-Jakob disease	0.00162	0.00239	CbGeAlD
Crizotinib—LCK—Downstream TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00162	0.00502	CbGpPWpGaD
Crizotinib—JAK2—cerebellum—Creutzfeldt-Jakob disease	0.00161	0.00237	CbGeAlD
Crizotinib—MAP4K5—central nervous system—Creutzfeldt-Jakob disease	0.00159	0.00234	CbGeAlD
Crizotinib—TEK—central nervous system—Creutzfeldt-Jakob disease	0.00159	0.00234	CbGeAlD
Crizotinib—MAP3K3—central nervous system—Creutzfeldt-Jakob disease	0.00159	0.00234	CbGeAlD
Crizotinib—PTK2B—brain—Creutzfeldt-Jakob disease	0.00157	0.00231	CbGeAlD
Crizotinib—JAK3—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00157	0.00487	CbGpPWpGaD
Crizotinib—MET—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00156	0.00485	CbGpPWpGaD
Crizotinib—CSF1R—spinal cord—Creutzfeldt-Jakob disease	0.00156	0.0023	CbGeAlD
Crizotinib—RIPK2—brain—Creutzfeldt-Jakob disease	0.00156	0.0023	CbGeAlD
Crizotinib—MAP3K3—cerebellum—Creutzfeldt-Jakob disease	0.00155	0.00229	CbGeAlD
Crizotinib—TEK—cerebellum—Creutzfeldt-Jakob disease	0.00155	0.00229	CbGeAlD
Crizotinib—MAP4K5—cerebellum—Creutzfeldt-Jakob disease	0.00155	0.00229	CbGeAlD
Crizotinib—JAK2—Interleukin-3, 5 and GM-CSF signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00155	0.00481	CbGpPWpGaD
Crizotinib—CYP3A4—blood plasma—Creutzfeldt-Jakob disease	0.00153	0.00226	CbGeAlD
Crizotinib—EPHA6—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00153	0.00475	CbGpPWpGaD
Crizotinib—EPHB6—central nervous system—Creutzfeldt-Jakob disease	0.00151	0.00223	CbGeAlD
Crizotinib—SRC—Alpha4 beta1 integrin signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00151	0.00469	CbGpPWpGaD
Crizotinib—EPHA4—brain—Creutzfeldt-Jakob disease	0.0015	0.00222	CbGeAlD
Crizotinib—EPHB6—cerebellum—Creutzfeldt-Jakob disease	0.00148	0.00218	CbGeAlD
Crizotinib—MAP3K2—brain—Creutzfeldt-Jakob disease	0.00148	0.00218	CbGeAlD
Crizotinib—YES1—central nervous system—Creutzfeldt-Jakob disease	0.00146	0.00216	CbGeAlD
Crizotinib—STK10—central nervous system—Creutzfeldt-Jakob disease	0.00145	0.00214	CbGeAlD
Crizotinib—TAOK3—central nervous system—Creutzfeldt-Jakob disease	0.00145	0.00213	CbGeAlD
Crizotinib—PTK2—brain—Creutzfeldt-Jakob disease	0.00144	0.00213	CbGeAlD
Crizotinib—TBK1—brain—Creutzfeldt-Jakob disease	0.00144	0.00213	CbGeAlD
Crizotinib—SRC—Class I PI3K signaling events mediated by Akt—YWHAZ—Creutzfeldt-Jakob disease	0.00144	0.00448	CbGpPWpGaD
Crizotinib—TYK2—brain—Creutzfeldt-Jakob disease	0.00144	0.00212	CbGeAlD
Crizotinib—YES1—cerebellum—Creutzfeldt-Jakob disease	0.00143	0.00211	CbGeAlD
Crizotinib—STK10—cerebellum—Creutzfeldt-Jakob disease	0.00142	0.00209	CbGeAlD
Crizotinib—IRAK1—brain—Creutzfeldt-Jakob disease	0.00142	0.00209	CbGeAlD
Crizotinib—TAOK3—cerebellum—Creutzfeldt-Jakob disease	0.00141	0.00208	CbGeAlD
Crizotinib—SRC—Trk receptor signaling mediated by PI3K and PLC-gamma—YWHAZ—Creutzfeldt-Jakob disease	0.00141	0.00438	CbGpPWpGaD
Crizotinib—EPHA2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00141	0.00438	CbGpPWpGaD
Crizotinib—SRC—central nervous system—Creutzfeldt-Jakob disease	0.00141	0.00208	CbGeAlD
Crizotinib—RIPK2—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.0014	0.00434	CbGpPWpGaD
Crizotinib—RPS6KB1—brain—Creutzfeldt-Jakob disease	0.00139	0.00205	CbGeAlD
Crizotinib—FGR—brain—Creutzfeldt-Jakob disease	0.00138	0.00204	CbGeAlD
Crizotinib—PTK2B—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00138	0.00428	CbGpPWpGaD
Crizotinib—ABL1—Pathogenic Escherichia coli infection—YWHAZ—Creutzfeldt-Jakob disease	0.00138	0.00428	CbGpPWpGaD
Crizotinib—SRC—cerebellum—Creutzfeldt-Jakob disease	0.00138	0.00203	CbGeAlD
Crizotinib—AXL—brain—Creutzfeldt-Jakob disease	0.00138	0.00203	CbGeAlD
Crizotinib—FES—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00136	0.00424	CbGpPWpGaD
Crizotinib—ABL1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00136	0.002	CbGeAlD
Crizotinib—SLK—brain—Creutzfeldt-Jakob disease	0.00132	0.00195	CbGeAlD
Crizotinib—LYN—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.00132	0.00408	CbGpPWpGaD
Crizotinib—EPHB4—brain—Creutzfeldt-Jakob disease	0.00131	0.00194	CbGeAlD
Crizotinib—JAK2—brain—Creutzfeldt-Jakob disease	0.00131	0.00193	CbGeAlD
Crizotinib—EPHA5—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00129	0.00402	CbGpPWpGaD
Crizotinib—ABL2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00129	0.00402	CbGpPWpGaD
Crizotinib—EPHA3—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00129	0.00402	CbGpPWpGaD
Crizotinib—MERTK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.00129	0.00401	CbGpPWpGaD
Crizotinib—EPHA2—brain—Creutzfeldt-Jakob disease	0.00129	0.0019	CbGeAlD
Crizotinib—CSF1R—central nervous system—Creutzfeldt-Jakob disease	0.00126	0.00186	CbGeAlD
Crizotinib—MAP4K5—brain—Creutzfeldt-Jakob disease	0.00126	0.00186	CbGeAlD
Crizotinib—TEK—brain—Creutzfeldt-Jakob disease	0.00126	0.00186	CbGeAlD
Crizotinib—MAP3K3—brain—Creutzfeldt-Jakob disease	0.00126	0.00186	CbGeAlD
Crizotinib—EPHA8—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00125	0.00387	CbGpPWpGaD
Crizotinib—CSF1R—cerebellum—Creutzfeldt-Jakob disease	0.00124	0.00182	CbGeAlD
Crizotinib—EPHB4—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00123	0.00383	CbGpPWpGaD
Crizotinib—EPHA4—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00123	0.00383	CbGpPWpGaD
Crizotinib—LIMK2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00123	0.00383	CbGpPWpGaD
Crizotinib—ABL1—spinal cord—Creutzfeldt-Jakob disease	0.00123	0.00182	CbGeAlD
Crizotinib—JAK2—Interferon gamma signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00122	0.00378	CbGpPWpGaD
Crizotinib—LCK—TCR signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.00121	0.00375	CbGpPWpGaD
Crizotinib—LIMK1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00121	0.00375	CbGpPWpGaD
Crizotinib—EPHB6—brain—Creutzfeldt-Jakob disease	0.0012	0.00177	CbGeAlD
Crizotinib—BLK—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.0012	0.00371	CbGpPWpGaD
Crizotinib—FGR—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00119	0.0037	CbGpPWpGaD
Crizotinib—YES1—brain—Creutzfeldt-Jakob disease	0.00116	0.00171	CbGeAlD
Crizotinib—EPHB6—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00116	0.0036	CbGpPWpGaD
Crizotinib—STK10—brain—Creutzfeldt-Jakob disease	0.00115	0.0017	CbGeAlD
Crizotinib—TAOK3—brain—Creutzfeldt-Jakob disease	0.00115	0.00169	CbGeAlD
Crizotinib—SRC—brain—Creutzfeldt-Jakob disease	0.00112	0.00165	CbGeAlD
Crizotinib—EPHA6—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00109	0.00339	CbGpPWpGaD
Crizotinib—ABCB1—blood plasma—Creutzfeldt-Jakob disease	0.00109	0.0016	CbGeAlD
Crizotinib—YES1—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00108	0.00336	CbGpPWpGaD
Crizotinib—LCK—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.00108	0.00335	CbGpPWpGaD
Crizotinib—IRAK1—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.00103	0.00319	CbGpPWpGaD
Crizotinib—EPHA2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.00101	0.00312	CbGpPWpGaD
Crizotinib—CSF1R—brain—Creutzfeldt-Jakob disease	0.001	0.00148	CbGeAlD
Crizotinib—ABL1—central nervous system—Creutzfeldt-Jakob disease	0.000999	0.00147	CbGeAlD
Crizotinib—TYK2—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.000996	0.00309	CbGpPWpGaD
Crizotinib—PRKD1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000978	0.00304	CbGpPWpGaD
Crizotinib—ABL1—cerebellum—Creutzfeldt-Jakob disease	0.000977	0.00144	CbGeAlD
Crizotinib—YES1—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000962	0.00299	CbGpPWpGaD
Crizotinib—SRC—Costimulation by the CD28 family—HLA-DQB1—Creutzfeldt-Jakob disease	0.000954	0.00296	CbGpPWpGaD
Crizotinib—JAK3—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000884	0.00275	CbGpPWpGaD
Crizotinib—PTK2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000874	0.00271	CbGpPWpGaD
Crizotinib—MAP3K3—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000874	0.00271	CbGpPWpGaD
Crizotinib—YES1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000862	0.00268	CbGpPWpGaD
Crizotinib—ABL1—Cell Cycle—YWHAZ—Creutzfeldt-Jakob disease	0.00084	0.00261	CbGpPWpGaD
Crizotinib—JAK3—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000824	0.00256	CbGpPWpGaD
Crizotinib—PTK2—Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.000822	0.00255	CbGpPWpGaD
Crizotinib—LYN—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.000807	0.0025	CbGpPWpGaD
Crizotinib—TYK2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000794	0.00247	CbGpPWpGaD
Crizotinib—ABL1—brain—Creutzfeldt-Jakob disease	0.000793	0.00117	CbGeAlD
Crizotinib—TYK2—Interferon Signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.000784	0.00243	CbGpPWpGaD
Crizotinib—MAP3K3—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000776	0.00241	CbGpPWpGaD
Crizotinib—JAK2—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.000755	0.00234	CbGpPWpGaD
Crizotinib—TXK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000742	0.0023	CbGpPWpGaD
Crizotinib—RIPK2—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000735	0.00228	CbGpPWpGaD
Crizotinib—JAK3—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000732	0.00227	CbGpPWpGaD
Crizotinib—PTK2B—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000724	0.00225	CbGpPWpGaD
Crizotinib—LYN—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000718	0.00223	CbGpPWpGaD
Crizotinib—ABL1—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000714	0.00222	CbGpPWpGaD
Crizotinib—JAK2—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000672	0.00209	CbGpPWpGaD
Crizotinib—LCK—Signaling by Interleukins—YWHAZ—Creutzfeldt-Jakob disease	0.000661	0.00205	CbGpPWpGaD
Crizotinib—RIPK2—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000652	0.00203	CbGpPWpGaD
Crizotinib—PTK2B—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000643	0.002	CbGpPWpGaD
Crizotinib—LYN—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000643	0.002	CbGpPWpGaD
Crizotinib—ABL1—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.00064	0.00199	CbGpPWpGaD
Crizotinib—PTK2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000624	0.00194	CbGpPWpGaD
Crizotinib—PTK2—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000619	0.00192	CbGpPWpGaD
Crizotinib—YES1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000615	0.00191	CbGpPWpGaD
Crizotinib—TEK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000605	0.00188	CbGpPWpGaD
Crizotinib—JAK2—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000602	0.00187	CbGpPWpGaD
Crizotinib—SRC—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.000599	0.00186	CbGpPWpGaD
Crizotinib—JAK2—Interferon Signaling—HLA-DQB1—Creutzfeldt-Jakob disease	0.000594	0.00185	CbGpPWpGaD
Crizotinib—LCK—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000588	0.00183	CbGpPWpGaD
Crizotinib—YES1—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000569	0.00177	CbGpPWpGaD
Crizotinib—TYK2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000566	0.00176	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000562	0.00175	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000555	0.00172	CbGpPWpGaD
Crizotinib—IRAK1—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000539	0.00167	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000534	0.00166	CbGpPWpGaD
Crizotinib—TXK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000529	0.00164	CbGpPWpGaD
Crizotinib—TYK2—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000524	0.00163	CbGpPWpGaD
Crizotinib—SRC—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.000521	0.00162	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000511	0.00159	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000511	0.00159	CbGpPWpGaD
Crizotinib—YES1—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000505	0.00157	CbGpPWpGaD
Crizotinib—ABCB1—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.000501	0.00156	CbGpPWpGaD
Crizotinib—IRAK1—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000479	0.00149	CbGpPWpGaD
Crizotinib—TXK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000469	0.00146	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—PRNP—Creutzfeldt-Jakob disease	0.000466	0.00145	CbGpPWpGaD
Crizotinib—TYK2—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000465	0.00144	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000459	0.00142	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000457	0.00142	CbGpPWpGaD
Crizotinib—JAK3—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000456	0.00142	CbGpPWpGaD
Crizotinib—LYN—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000455	0.00141	CbGpPWpGaD
Crizotinib—CYP3A4—central nervous system—Creutzfeldt-Jakob disease	0.000439	0.000648	CbGeAlD
Crizotinib—STK4—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000438	0.00136	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.00043	0.00133	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000429	0.00133	CbGpPWpGaD
Crizotinib—JAK2—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000426	0.00132	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000424	0.00132	CbGpPWpGaD
Crizotinib—ABCB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.000423	0.000623	CbGeAlD
Crizotinib—TBK1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000418	0.0013	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000401	0.00124	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000401	0.00124	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000397	0.00123	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000396	0.00123	CbGpPWpGaD
Crizotinib—FGR—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.00039	0.00121	CbGpPWpGaD
Crizotinib—ABCB1—spinal cord—Creutzfeldt-Jakob disease	0.000383	0.000565	CbGeAlD
Crizotinib—BLK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000381	0.00118	CbGpPWpGaD
Crizotinib—JAK3—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000378	0.00117	CbGpPWpGaD
Crizotinib—LYN—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000376	0.00117	CbGpPWpGaD
Crizotinib—LCK—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.000373	0.00116	CbGpPWpGaD
Crizotinib—SRC—Membrane Trafficking—YWHAZ—Creutzfeldt-Jakob disease	0.000372	0.00116	CbGpPWpGaD
Crizotinib—STK3—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000372	0.00116	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000364	0.00113	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000364	0.00113	CbGpPWpGaD
Crizotinib—IKBKE—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000356	0.0011	CbGpPWpGaD
Crizotinib—JAK2—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000352	0.00109	CbGpPWpGaD
Crizotinib—RIPK2—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000351	0.00109	CbGpPWpGaD
Crizotinib—LCK—Cytokine Signaling in Immune system—HLA-DQB1—Creutzfeldt-Jakob disease	0.000347	0.00108	CbGpPWpGaD
Crizotinib—BLK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000338	0.00105	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000337	0.00105	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—PRNP—Creutzfeldt-Jakob disease	0.000333	0.00103	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000332	0.00103	CbGpPWpGaD
Crizotinib—SRC—Platelet activation, signaling and aggregation—YWHAZ—Creutzfeldt-Jakob disease	0.00033	0.00102	CbGpPWpGaD
Crizotinib—BLK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000324	0.00101	CbGpPWpGaD
Crizotinib—MAPK7—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000324	0.001	CbGpPWpGaD
Crizotinib—LIMK1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000324	0.001	CbGpPWpGaD
Crizotinib—FGR—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000323	0.001	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.00032	0.000995	CbGpPWpGaD
Crizotinib—PTK2—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000319	0.00099	CbGpPWpGaD
Crizotinib—YES1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000314	0.000976	CbGpPWpGaD
Crizotinib—ACVR1B—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000312	0.000969	CbGpPWpGaD
Crizotinib—FER—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000312	0.000969	CbGpPWpGaD
Crizotinib—ABCB1—central nervous system—Creutzfeldt-Jakob disease	0.000311	0.000458	CbGeAlD
Crizotinib—LCK—Cytokine Signaling in Immune system—YWHAZ—Creutzfeldt-Jakob disease	0.000309	0.000958	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000306	0.000951	CbGpPWpGaD
Crizotinib—ABCB1—cerebellum—Creutzfeldt-Jakob disease	0.000304	0.000448	CbGeAlD
Crizotinib—TBK1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000298	0.000924	CbGpPWpGaD
Crizotinib—AXL—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000296	0.000918	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000285	0.000886	CbGpPWpGaD
Crizotinib—YES1—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000272	0.000844	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00027	0.00084	CbGpPWpGaD
Crizotinib—JAK3—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000269	0.000836	CbGpPWpGaD
Crizotinib—TBK1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000264	0.000821	CbGpPWpGaD
Crizotinib—PTK2—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000264	0.000821	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000263	0.000815	CbGpPWpGaD
Crizotinib—YES1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000261	0.000809	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000257	0.000797	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000253	0.000787	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000247	0.000768	CbGpPWpGaD
Crizotinib—ABCB1—brain—Creutzfeldt-Jakob disease	0.000247	0.000364	CbGeAlD
Crizotinib—TYK2—Immune System—CTSD—Creutzfeldt-Jakob disease	0.00024	0.000745	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00024	0.000745	CbGpPWpGaD
Crizotinib—JAK3—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000239	0.000742	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000236	0.000734	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000236	0.000734	CbGpPWpGaD
Crizotinib—LYN—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000234	0.000728	CbGpPWpGaD
Crizotinib—ABL1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000233	0.000725	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CTSD—Creutzfeldt-Jakob disease	0.000232	0.000722	CbGpPWpGaD
Crizotinib—BLK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000231	0.000717	CbGpPWpGaD
Crizotinib—FGR—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00023	0.000714	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000228	0.000709	CbGpPWpGaD
Crizotinib—CDK7—Gene Expression—YWHAZ—Creutzfeldt-Jakob disease	0.000222	0.00069	CbGpPWpGaD
Crizotinib—JAK2—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000219	0.000681	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000214	0.000664	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000213	0.000662	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.00021	0.000652	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000209	0.00065	CbGpPWpGaD
Crizotinib—CDK7—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000206	0.00064	CbGpPWpGaD
Crizotinib—BLK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000205	0.000636	CbGpPWpGaD
Crizotinib—FGR—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000204	0.000634	CbGpPWpGaD
Crizotinib—LYN—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000203	0.000629	CbGpPWpGaD
Crizotinib—LYN—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000194	0.000603	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000194	0.000601	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000193	0.000601	CbGpPWpGaD
Crizotinib—LCK—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000192	0.000597	CbGpPWpGaD
Crizotinib—PTK2—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000188	0.000585	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000187	0.000581	CbGpPWpGaD
Crizotinib—YES1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000186	0.000577	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000182	0.000565	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000176	0.000547	CbGpPWpGaD
Crizotinib—TYK2—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000171	0.000531	CbGpPWpGaD
Crizotinib—SRC—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.00017	0.000528	CbGpPWpGaD
Crizotinib—PTK2—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000167	0.000519	CbGpPWpGaD
Crizotinib—LCK—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000166	0.000516	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000166	0.000514	CbGpPWpGaD
Crizotinib—YES1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000165	0.000512	CbGpPWpGaD
Crizotinib—LCK—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000159	0.000495	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000156	0.000486	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000155	0.00048	CbGpPWpGaD
Crizotinib—TYK2—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000152	0.000471	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000147	0.000457	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000142	0.00044	CbGpPWpGaD
Crizotinib—SRC—Immune System—CTSD—Creutzfeldt-Jakob disease	0.000141	0.000438	CbGpPWpGaD
Crizotinib—TYK2—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.00014	0.000435	CbGpPWpGaD
Crizotinib—LYN—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000138	0.00043	CbGpPWpGaD
Crizotinib—ABL1—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000138	0.000428	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000138	0.000428	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000136	0.000422	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00013	0.000403	CbGpPWpGaD
Crizotinib—JAK2—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.00013	0.000402	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000126	0.000391	CbGpPWpGaD
Crizotinib—LYN—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000123	0.000382	CbGpPWpGaD
Crizotinib—ABL1—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000122	0.00038	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000119	0.00037	CbGpPWpGaD
Crizotinib—JAK2—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000115	0.000357	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.000113	0.000352	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000108	0.000336	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000107	0.000332	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000107	0.000331	CbGpPWpGaD
Crizotinib—JAK2—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000106	0.00033	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000101	0.000314	CbGpPWpGaD
Crizotinib—LCK—Immune System—YWHAZ—Creutzfeldt-Jakob disease	0.000101	0.000313	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DQB1—Creutzfeldt-Jakob disease	0.0001	0.000312	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	9.82e-05	0.000305	CbGpPWpGaD
Crizotinib—LCK—Disease—YWHAZ—Creutzfeldt-Jakob disease	9.3e-05	0.000289	CbGpPWpGaD
Crizotinib—SRC—Immune System—YWHAZ—Creutzfeldt-Jakob disease	8.92e-05	0.000277	CbGpPWpGaD
Crizotinib—SRC—Disease—YWHAZ—Creutzfeldt-Jakob disease	8.24e-05	0.000256	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	7.95e-05	0.000247	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	7.44e-05	0.000231	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NPAS2—Creutzfeldt-Jakob disease	6.59e-05	0.000205	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	6.52e-05	0.000202	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	5.77e-05	0.000179	CbGpPWpGaD
